[Neuromeningeal irradiation during the treatment of acute lymphoblastic leukemia].
D000208:Acute Disease; D000367:Age Factors; D001215:Asparaginase / Q000627:therapeutic use; D002330:Carmustine / Q000627:therapeutic use; D002490:Central Nervous System; D002648:Child; D002675:Child, Preschool; D003037:Cobalt Radioisotopes / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000532:radiotherapy*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011867:Radioisotope Teletherapy; D011879:Radiotherapy Dosage; D013997:Time Factors; D014750:Vincristine / Q000627:therapeutic use
D003037:Cobalt Radioisotopes; D014750:Vincristine; D003520:Cyclophosphamide; D001215:Asparaginase; D002330:Carmustine; D011241:Prednisone; D008727:Methotrexate
Irradiations neuro-méningées au cours du traitement de la leucémie lymphoblastique aiguë